E-Cadherin as a Prognostic Indicator in Primary Breast Cancer

British Journal of Cancer - United Kingdom
doi 10.1054/bjoc.2001.2178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Immunofluorometrically Determined P53 Accumulation as a Prognostic Indicator in Italian Breast Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
1998English

Prognostic Value of Lymphocyte Vascular Density and E-Cadherin in Inflammatory Breast Cancer

Journal of Cancer Therapy
2014English

TAZ Expression as a Prognostic Indicator in Colorectal Cancer

PLoS ONE
Multidisciplinary
2013English

Level of Topoisomerase IIα Expression as a Prognostic Indicator in Patients With Breast Cancer (Literature Review)

Practical oncology
2018English

Elafin, an Inhibitor of Elastase, Is a Prognostic Indicator in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2013English

Nature and Prognostic Significance of Alterations in the DCC and E-Cadherin Genes in Breast Cancer

1999English

TLR5: A Prognostic and Monitoring Indicator for Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer

Cancer Discovery
Oncology
2018English

Comparison Study of E-Cadherin Expression in Primary Breast Cancer and Its Corresponding Metastatic Lymph Node

Journal of Cytology & Histology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy